This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04520/identifier/pdb/
n14http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB04520/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04520/identifier/pubchem-substance/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n5http://linked.opendata.cz/resource/drugbank/drug/DB04520/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB04520/identifier/chemspider/

Statements

Subject Item
n2:DB04520
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB04520 n14:DB04520
dcterms:title
(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione
adms:identifier
n5:DB04520 n7:TYP n8:106647 n11:119404 n13:46507651
n3:IUPAC-Name
n6:271B61B0-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B61B6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B61B5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B61B2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B61B3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B61B4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B61AE-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B61AF-363D-11E5-9242-09173F13E4C5 n6:271B61AC-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B61AD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B61BC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B61BD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B61B7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B61B8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B61BA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B61B9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B61BB-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B61C2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B61C4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B61C5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B61C1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B61C0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B61C3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B61B1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B61BE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B61BF-363D-11E5-9242-09173F13E4C5